Participant flow12

How many started, completed or left each group, period by period.

1 to 12 of 12

Period	Milestone	Group	Participants
Overall Study	STARTED	Placebo	119
Overall Study	STARTED	Nizoral	230
Overall Study	STARTED	Ketoconazole	234
Overall Study	Positive Baseline Culture Set	Placebo	56
Overall Study	Positive Baseline Culture Set	Nizoral	111
Overall Study	Positive Baseline Culture Set	Ketoconazole	114
Overall Study	COMPLETED	Placebo	104
Overall Study	COMPLETED	Nizoral	207
Overall Study	COMPLETED	Ketoconazole	208
Overall Study	NOT COMPLETED	Placebo	15
Overall Study	NOT COMPLETED	Nizoral	23
Overall Study	NOT COMPLETED	Ketoconazole	26

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01110330/flow